digital yuan currency Top People also ask

New Oriental acquired Taimei International Travel Service. Tianyancha App shows that recently, Taimei (Beijing) International Travel Service Co., Ltd. has undergone industrial and commercial changes, and Tianjin Vision Contemporary Technology Co., Ltd., the original wholly-owned shareholder, has withdrawn, and Beijing New Oriental Wokaide International Education Travel Co., Ltd. has been added as a shareholder and wholly owned. At the same time, the legal representative and several key personnel have changed. Taimei (Beijing) International Travel Service Co., Ltd. was established in May 2016. Its legal representative is Longhua with a registered capital of RMB 5 million. Its business scope covers domestic tourism business, inbound tourism business, outbound tourism business, exhibition activities, conference services, ticketing agents and air ticket sales agents.Lu Kang led a delegation to visit the United States and had an in-depth exchange of views with people from all walks of life on Sino-US relations. From December 1 to 7, Lu Kang, Vice Minister of the International Liaison Department of the CPC Central Committee, led a delegation to visit the United States. In Washington, new york, and San Francisco, Lu Kang met with officials from the White House and the State Council, members of Congress, and relevant people from business circles, think tanks, media, universities, societies, enterprises, etc., and exchanged in-depth views on Sino-US relations. (official website of the International Liaison Department)FTSE China A50 index futures rose 1%.

In the concept of ice and snow economy, there were many daily limit changes, such as iceberg cold and hot, iceberg cold and hot, Longjian shares and Jingxue energy-saving daily limit, and Dalian Shengya, Changbai Mountain, Yeti shares and Sante ropeway were among the top gainers.Ma Huateng: Contributing to the economic recovery, Ma Huateng said in People's Daily that Tencent, as a digital technology enterprise, actively responded to the deployment of the country to expand domestic demand and actively explored the development of digital consumption. By optimizing consumer tools such as WeChat payment, the company tries to create and serve effective demand and promote economic cycle by testing the e-commerce business such as live delivery of water video numbers. At the same time, Tencent relies on the WeChat ecosystem to enhance the absorption and friendliness of employment and entrepreneurship. Last year, it provided employment income opportunities for more than 50 million people. In the future, Tencent will also increase investment, devote itself to technological innovation and industrial upgrading, and jointly contribute to the stable and healthy development of China's economy with the vast number of private enterprises. (People's Network)In the inter-bank market, the yield of the active 10-year treasury bond "24 Treasury Bond with Interest 11" dropped by 1bp to 1.815%. Wind data shows that compared with yield to maturity, a Chinese bond with the same term, it hit a record low.

The next "explosion point" of biomedicine may appear in Shenzhen. "China's pharmaceutical innovation ranks first in the second echelon in the world in terms of the quantitative indicators of R&D pipelines and listed new drugs." A few days ago, Song Ruilin, executive president of China Pharmaceutical Innovation Promotion Association, held the "Star of the Bay Area" biomedical source innovation conference in Shenzhen, and believed that China's pharmaceutical research and industrial development were entering a new stage of innovation. Chen Qiyu, vice president of China Pharmaceutical Innovation Promotion Association and executive director and co-CEO of Fosun International, said that Shenzhen has great advantages and development momentum in linking Greater Bay Area's urban development and AI technology. By leveraging the resources in the Bay Area and making good use of these advantages, it is possible to find a new fulcrum in the future biomedical R&D innovation track, and the next "explosion point" of biomedicine is likely to appear in Shenzhen.BYD's legal department sued the blogger "Xu Lili Xll" and demanded compensation of 5 million yuan. BYD's legal department issued a statement saying that it was concerned that the online user "Xu Lili Xll" had made a lot of false statements against BYD and its sub-brands for a long time, which had caused serious damage to the company's brand reputation. In this regard, the company has fixed the evidence of relevant false statements, and decided to formally file a lawsuit against "Xu Lili Xll", demanding that it delete the infringing statements, eliminate the influence, and compensate RMB 5 million.The next "explosion point" of biomedicine may appear in Shenzhen. "China's pharmaceutical innovation ranks first in the second echelon in the world in terms of the quantitative indicators of R&D pipelines and listed new drugs." A few days ago, Song Ruilin, executive president of China Pharmaceutical Innovation Promotion Association, held the "Star of the Bay Area" biomedical source innovation conference in Shenzhen, and believed that China's pharmaceutical research and industrial development were entering a new stage of innovation. Chen Qiyu, vice president of China Pharmaceutical Innovation Promotion Association and executive director and co-CEO of Fosun International, said that Shenzhen has great advantages and development momentum in linking Greater Bay Area's urban development and AI technology. By leveraging the resources in the Bay Area and making good use of these advantages, it is possible to find a new fulcrum in the future biomedical R&D innovation track, and the next "explosion point" of biomedicine is likely to appear in Shenzhen.